Companies / Tetra Therapeutics
Tetra Therapeutics
Florham Park, United States
Tetra Therapeutics was acquired by Shionogi and its clinical trials and research programs are now managed by Shionogi Inc.
Tetra Therapeutics, based in Florham Park, United States, has 2 investors on file, among them Dolby Family Ventures and Michigan Capital Network.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Dolby Family Ventures
91 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (35%), AI & Machine Learning (26%), Industrial & Manufacturing (11%).
See Dolby Family Ventures' full profile · Who invests alongside it
More from Michigan Capital Network
36 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (35%), AI & Machine Learning (18%), Industrial & Manufacturing (12%).
See Michigan Capital Network's full profile · Who invests alongside it
Recent changes
what VCinfo saw changeA company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Tetra Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Dolby Family Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/tetradiscovery.com/investors
# also
GET /v1/companies/tetradiscovery.com
GET /v1/companies/tetradiscovery.com/news